media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Concord Drugs Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]51.3158.9651.3651.3448.08
Total Operating Revenues51.3158.9651.3651.3448.08
      
Other Income0.010.100.090.120.09
Total Revenue51.3259.0651.4551.4648.16
      
EXPENSES     
Cost Of Materials Consumed40.3646.7537.8343.1738.01
Purchase Of Stock-In Trade0.000.002.66-1.111.13
Changes In Inventories Of FG,WIP And Stock-In Trade0.52-4.651.690.520.46
Employee Benefit Expenses4.634.893.763.512.53
Finance Costs1.621.681.421.541.59
Depreciation And Amortisation Expenses1.601.761.371.461.71
Other Expenses1.476.372.201.912.29
Total Expenses50.2056.8150.9251.0047.72
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1.132.250.530.460.44
      
Exceptional Items0.000.003.760.000.00
Profit/Loss Before Tax1.132.254.290.460.44
      
Tax Expenses-Continued Operations     
Current Tax0.350.670.470.120.12
Deferred Tax-0.11-0.020.540.01-0.08
Total Tax Expenses0.230.651.010.130.03
Profit/Loss After Tax And Before ExtraOrdinary Items0.891.593.280.330.41
      
Profit/Loss From Continuing Operations0.891.593.280.330.41
      
Profit/Loss For The Period0.891.593.280.330.41
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)0.961.823.750.380.52
Diluted EPS (Rs.)0.961.823.750.380.52
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]51.31
Total Operating Revenues51.31
Other Income0.01
Total Revenue51.32
EXPENSES 
Cost Of Materials Consumed40.36
Purchase Of Stock-In Trade0.00
Changes In Inventories Of FG,WIP And Stock-In Trade0.52
Employee Benefit Expenses4.63
Finance Costs1.62
Depreciation And Amortisation Expenses1.60
Other Expenses1.47
Total Expenses50.20
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1.13
Exceptional Items0.00
Profit/Loss Before Tax1.13
Tax Expenses-Continued Operations 
Current Tax0.35
Deferred Tax-0.11
Total Tax Expenses0.23
Profit/Loss After Tax And Before ExtraOrdinary Items0.89
Profit/Loss From Continuing Operations0.89
Profit/Loss For The Period0.89
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)0.96
Diluted EPS (Rs.)0.96